Vicor
VICR
282.78
-16.51
-5.52%
Vicor
US · VICR
#1215 by market cap
Listed 1970
282.78
-16.51
-5.52%
Live - 5344 symbols - heartbeat 91s ago
· 2026-10-08 08:33
Pre-market
277.00
-2.04%
After-hours
282.03
-0.26%
Overnight
276.05
-2.38%
- Market cap
- 13.04B
- P/E (TTM)i
- 90.63
- P/Bi
- 15.63
- EPSi
- 2.61
- Div yieldi
- 0.00%
- 52W posi
- 70%
Reader sentiment
Are you bullish or bearish on VICR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 108.16, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +26.08% YoY
Margins
- Gross margin
- 57.31%
- Operating margin
- 18.08%
- Net margin
- 26.19%
Key ratios & quality
- PEG ratioi
- 1.35
- Altman Z-Scorei
- 108.16
PEG uses trailing P/E against the 3-year net income growth rate (67.02%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 291.22M | 262.98M | 296.58M | 359.36M | 399.08M | 405.06M | 359.06M | 452.70M |
| Gross profit | 138.97M | 122.97M | 131.45M | 178.20M | 180.56M | 204.93M | 184.00M | 259.43M |
| Selling & admin expenses | 62.22M | 62.56M | 63.16M | 69.48M | 86.26M | 85.71M | 96.89M | 99.03M |
| Research & development | 44.29M | 46.59M | 50.92M | 53.11M | 60.59M | 67.86M | 68.92M | 78.57M |
| Operating profit | 32.46M | 13.82M | 17.37M | 55.60M | 33.70M | 51.36M | 18.19M | 81.83M |
| Pretax profit | 32.93M | 14.89M | 18.46M | 56.81M | 28.69M | 60.24M | 10.49M | 94.57M |
| Tax | 1.09M | 778.00K | 539.00K | 176.00K | 3.26M | 6.64M | 4.35M | -24.03M |
| Net profit | 31.85M | 14.11M | 17.92M | 56.63M | 25.43M | 53.60M | 6.14M | 118.60M |
| Basic EPS | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 3 |
| Diluted EPS | 0.78 | 0.34 | 0.41 | 1.26 | 0.57 | 1.19 | 0.14 | 2.61 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 93.97M | 141.05M | 110.42M | 107.26M | 112.97M | 143.35M |
| Gross profit | 44.37M | 92.13M | 63.51M | 59.42M | 62.37M | 83.12M |
| Selling & admin expenses | 25.14M | 27.95M | 22.75M | 23.20M | 23.19M | 27.60M |
| Research & development | 19.38M | 18.79M | 19.86M | 20.54M | 22.29M | 20.64M |
| Operating profit | -149.00K | 45.39M | 20.91M | 15.69M | 16.88M | 34.88M |
| Pretax profit | 2.99M | 49.04M | 23.31M | 19.23M | 20.40M | 38.92M |
| Tax | 424.00K | 7.84M | -4.99M | -27.30M | -273.00K | -10.86M |
| Net profit | 2.56M | 41.20M | 28.30M | 46.53M | 20.68M | 49.79M |
| Basic EPS | 0 | 1 | 1 | 1 | 0 | 1 |
| Diluted EPS | 0.06 | 0.91 | 0.63 | 1.01 | 0.44 | 1.04 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 165.06M | 179.07M | 316.93M | 356.76M | 362.60M | 420.37M | 463.03M | 587.36M |
| Cash & ST investments | 70.56M | 84.67M | 211.91M | 227.63M | 190.61M | 242.22M | 277.27M | 402.81M |
| Inventory | 47.37M | 49.19M | 57.27M | 67.32M | 101.41M | 106.58M | 106.03M | 91.34M |
| Total assets | 221.07M | 240.73M | 396.24M | 477.21M | 536.90M | 594.89M | 641.12M | 785.83M |
| Total current liabilities | 36.00M | 29.93M | 40.51M | 49.09M | 64.55M | 44.17M | 61.82M | 65.32M |
| Short-term debt | -- | 1.52M | 1.63M | 1.55M | 1.45M | 1.86M | 1.72M | 1.57M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 36,978,000.00 | 34,857,000.00 | 45,084,000.00 | 53,300,000.00 | 72,565,000.00 | 53,781,000.00 | 70,827,000.00 | 74,015,000.00 |
| Total equity | 184.09M | 205.87M | 351.16M | 423.91M | 464.34M | 541.11M | 570.29M | 711.82M |
| Retained earnings | 129.00M | 143.10M | 161.01M | 217.63M | 243.08M | 296.67M | 302.80M | 421.36M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 486.96M | 514.78M | 533.91M | 587.36M | 599.47M | 670.35M |
| Cash & ST investments | 296.10M | 338.54M | 362.38M | 402.81M | 404.25M | 453.58M |
| Inventory | 98.52M | 95.49M | 92.29M | 91.34M | 94.83M | 104.49M |
| Total assets | 665.04M | 693.51M | 710.25M | 785.83M | 804.88M | 894.16M |
| Total current liabilities | 75.66M | 73.84M | 70.69M | 65.32M | 41.93M | 50.60M |
| Short-term debt | 1.68M | 1.70M | 1.58M | 1.57M | 1.43M | 1.77M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 84,475,000.00 | 84,643,000.00 | 79,894,000.00 | 74,015,000.00 | 50,756,000.00 | 59,568,000.00 |
| Total equity | 580.56M | 608.87M | 630.35M | 711.82M | 754.13M | 834.59M |
| Retained earnings | 305.34M | 346.53M | 374.83M | 421.36M | 442.02M | 491.80M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 36.17M | 22.21M | 34.74M | 54.44M | 22.94M | 74.53M | 50.84M | 139.55M |
| Depreciation & amortization | 9.25M | 10.33M | 11.06M | 11.71M | 13.78M | 17.24M | 18.63M | 20.79M |
| Free cash flow | 17.96M | 9.73M | 6.09M | 6.68M | -41.03M | 41.08M | 27.24M | 119.23M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 109.68M | -- | 0 | 0 | -497.00K | -35.18M |
| Ending cash balance | 70.56M | 84.67M | 161.74M | 182.42M | 190.61M | 242.22M | 277.27M | 402.81M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 20.13M | 65.23M | 38.49M | 15.71M | -3.94M | 34.14M |
| Depreciation & amortization | 5.19M | 5.19M | 5.24M | 5.17M | 5.34M | 5.42M |
| Free cash flow | 15.58M | 59.02M | 34.47M | 10.17M | -16.33M | 22.97M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -15.37M | -2.20M | -- | -- |
| Ending cash balance | 296.10M | 338.54M | 362.38M | 402.81M | 404.25M | 453.58M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 19.84 | 7.24 | 6.44 | 14.62 | 5.73 | 10.67 | 1.10 | 18.50 |
| ROA %i | 16.40 | 6.11 | 5.62 | 12.97 | 5.02 | 9.47 | 0.99 | 16.62 |
| ROIC %i | 19.69 | 6.94 | 6.30 | 14.21 | 5.39 | 9.06 | -0.52 | 16.82 |
| 5-year avg ROE %i | 1.72 | 5.25 | 5.79 | 9.65 | 10.78 | 8.94 | 7.71 | 10.13 |
| EBIT margin %i | 11.15 | 5.26 | 5.86 | 15.47 | 8.44 | 12.68 | 5.07 | 18.08 |
| FCF / sales %i | 6.17 | 3.70 | 1.99 | 1.86 | -- | 10.14 | 7.59 | 26.34 |
| Current ratioi | 4.59 | 5.98 | 7.82 | 7.27 | 5.62 | 9.52 | 7.49 | 8.99 |
| Quick ratioi | 3.17 | 4.10 | 6.24 | 5.76 | 3.97 | 6.68 | 5.34 | 7.10 |
| Debt / assetsi | 0.05 | 1.82 | 1.16 | 1.00 | 1.58 | 1.38 | 1.14 | 0.91 |
| LT debt / equityi | 0.06 | 1.39 | 0.85 | 0.76 | 1.51 | 1.18 | 0.99 | 0.79 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 9.77 | 9.50 | 9.19 | 7.26 | 14.92 | 10.95 | -0.03 | 4.29 |
| Net income CAGR (3Y) %i | 86.04 | -- | 375.11 | 21.30 | 21.76 | 44.10 | -52.34 | 67.02 |
| FCF CAGR (3Y) %i | 96.23 | -- | -- | -28.07 | -- | 88.95 | 59.74 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 4.16 | 11.44 | 13.89 | 18.50 | 20.49 | 20.13 |
| ROA %i | 3.64 | 10.03 | 12.25 | 16.62 | 18.60 | 18.30 |
| ROIC %i | 2.36 | 9.50 | 11.89 | 16.82 | 19.14 | 18.85 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.59 | 14.10 | 17.06 | 18.08 | 20.96 | 18.64 |
| FCF / sales %i | 12.87 | 22.88 | 26.60 | 26.34 | 18.51 | 10.82 |
| Current ratioi | 6.44 | 6.97 | 7.55 | 8.99 | 14.30 | 13.25 |
| Quick ratioi | 4.78 | 5.33 | 5.88 | 7.10 | 11.25 | 10.52 |
| Debt / assetsi | 1.06 | 1.11 | 1.04 | 0.91 | 0.89 | 0.85 |
| LT debt / equityi | 0.92 | 0.98 | 0.92 | 0.79 | 0.76 | 0.70 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Advanced products is the largest reported line at 65.69% of revenue, across 2 reported segments.
- Brick Products follows at 34.31%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Advanced products65.69%
Brick Products34.31%
Quote time 2026-10-08 08:33:26 · For reference only, not investment advice and not tailored to your situation.